2026-08-11 Drugs SFDA Becomes First Regulatory Authority Globally to Approve the Registration of 'ZENBEXUS' for the Treatment of Multiple Myeloma in Adults
2026-07-02 The Authority mRNA Technology Shapes the Future of Modern Therapies: SFDA Advances Regulatory Frameworks to Foster Innovation and Protect Patient Safety
2026-06-29 Drugs SFDA Approves Registration of “Iqirvo” for the Treatment of Primary Biliary Cholangitis
2026-06-22 The Authority SFDA Grants Marketing Authorization for AI-Powered Medical App to Measure Vital Signs
2026-06-07 Drugs SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1)
